Striverdi Respimat Dosage/Direction for Use

Posology: The medicinal product is intended for inhalation use only. The cartridge can only be inserted and used in the Respimat inhaler.
Two puffs from the Respimat inhaler comprise one medicinal dose.
Adults: The recommended dose is 5 microgram olodaterol given as two puffs from the Respimat inhaler once daily, at the same time of the day.
The recommended dose should not be exceeded.
Elderly population: Elderly patients can use STRIVERDI RESPIMAT at the recommended dose.
Hepatic impairment: Patients with mild to moderate hepatic impairment can use Striverdi Respimat at the recommended dose.
There are no data available for the use of STRIVERDI RESPIMAT in patients with severe hepatic impairment.
Renal impairment: Renally impaired patients can use STRIVERDI RESPIMAT at the recommended dose.
There is limited experience with the use of STRIVERDI RESPIMAT in patients with severe renal impairment.
Paediatric population: There is no relevant use of STRIVERDI RESPIMAT in the paediatric population (under 18 years).
Method of administration: To ensure proper administration of the medicinal product, the patient should be shown how to use the inhaler by a physician or other health professional.